OUR PRODUCTS

MOBILE APPS

GENERAL INFO

GERN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Geron (GERN) Earnings Date & Reports

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

GERN is expected to report earnings to rise 53.50% to -3 cents per share on November 06

Q3'25

Est.

$-0.03

Q2'25

Beat

by $0.01

Q1'25

Est.

$-0.03

Q4'24

Missed

by $0.01

Q3'24

Beat

by $0.04

The last earnings report on August 06 showed earnings per share of -1 cents, beating the estimate of -2 cents. With 6.07M shares outstanding, the current market capitalization sits at 885.32M.

View a ticker or compare two or three

Compare

GERN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For GERN
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GERN showed earnings on August 06, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of therapeutic products for cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

919 East Hillsdale Boulevard

Phone

+1 650 473-7700

Employees

141

Web

https://www.geron.com